Effects of GSK598809 on Brain Activation in Abstinent Alcoholics

NCT00908206 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study not approved by BfARM

Conditions

Substance Dependence
Alcohol Dependence

Interventions

DRUG: GSK598809

Sponsor

GlaxoSmithKline